REVVITY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 110.2 USD | +1.63% |
|
+5.18% | +0.84% |
| 04-30 | TD Cowen Adjusts Price Target on Revvity to $130 From $123 | MT |
| 04-30 | JPMorgan Adjusts Price Target on Revvity to $105 From $100, Neutral Rating Maintained | MT |
Presenter SpeechMax Masucci (Analysts)We have Max Krakowiak, CFO, PerkinElmer. Thank you to bo...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Revvity, Inc. (formerly PerkinElmer, Inc.) specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales (including intragroup) break down by family of products as follows:
- medical diagnosis equipment (61%);
- analytical tools and instruments (39%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc.
Net sales are distributed geographically as follows: the United States (46.7%), China (14.4%), the United Kingdom (4.1%) and other (34.8%).
Calendar
18/07/2024
- Ex-dividend day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
110.2
USD
Average target price
123.7
USD
Spread / Average Target
+12.19%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.84% | 13.6B | |
| +12.15% | 227B | |
| +14.90% | 197B | |
| +18.22% | 141B | |
| +29.15% | 110B | |
| +0.53% | 64.15B | |
| +16.92% | 53.72B | |
| +6.33% | 51.75B | |
| +10.93% | 45.2B | |
| +5.87% | 37.37B |
- Stock Market
- Equities
- RVTY Stock
- News Revvity, Inc.
- Transcript : PerkinElmer, Inc. Presents at Cowen 43rd Annual Healthcare Conference, Mar-06-2023 09
